Skip to main content
Be The Investor
Home›Stocks›BMY

Bristol-Myers Squibb Company

BMY
NYSEUnited States flagUSReal-Time Price
$62.32USD
-0.59 (-0.94%)Today
$62.50+0.18 (+0.29%)After HoursLast quote · Nov 12, 2026, 4:43 PM ET

Investors Sentoments

Sign in to share your view.

BTI Score

BASIC required or higher

View pricing
BTI Fair Market Cap
$132.22B
-3.65% vs fair
Healthcare & Pharma
Hold

Bristol-Myers Squibb Company (BMY) Stock Analysis

BTI's proprietary analysis of Bristol-Myers Squibb Company (BMY): overall score, long- and short-term outlook, risk rating and fair-value verdict based on fundamentals, valuation and momentum.

Major-Firm Consensus
Hold
Filtered to 34 major global investment banks
Buy
14
Hold
19
Sell
1
Price Target Consensus
High
$80.00
Consensus
$65.25
Low
$40.00
Current
$62.32
Upside: +4.7%
Target Trend
Last Month— (0)
Last Quarter— (0)
Last Year— (0)
Ratings History — Major Investment Banks
FirmRatingActionPreviousPrice TargetUpsideDate
BMO CapitalHoldMaintains—$60.00-3.7%Nov 10, 2026
RBC CapitalHoldMaintains—$64.00+2.7%Nov 5, 2026
BernsteinHoldMaintains—$61.00-2.1%Nov 3, 2026
Wells FargoHoldMaintains———Oct 30, 2026
Morgan StanleySellReiterates———Oct 30, 2026
ScotiabankHoldMaintains—$60.00-3.7%Oct 30, 2026
Cantor FitzgeraldHoldMaintains—$53.00-15.0%Oct 30, 2026
GuggenheimBuyReiterates—$75.00+20.3%Oct 30, 2026
Annual Analyst Estimates
Fiscal YearRevenue AvgRevenue RangeEPS AvgEPS RangeAnalysts
FY 2026$50.23B— – —$6.44— – ——
FY 2027$48.80B— – —$6.70— – ——
Want deeper AI-powered analysis?
Get BTI AI's full investment thesis, valuation models, and risk assessment for BMY.